We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Supernus Pharmaceuticals
SUPN
$2.77B
| $800K | ﹤0.01% |
23,452
-171,330
| -88% | -$5.1M |
|
2052
Banco Macro
BMA
$5.35B
| $800K | ﹤0.01% |
16,600
-15,000
| -47% | -$530K |
|
2053
Intuitive Surgical
ISRG
$134B
| $799K | ﹤0.01% |
2,003
-150,408
| -99% | -$56.8M |
|
2054
Corsair Gaming
CRSR
$1.55B
| $794K | ﹤0.01% |
64,341
-33,648
| -34% | -$437K |
|
|
SWTX
2055
DELISTED
SpringWorks Therapeutics
SWTX
| $793K | ﹤0.01% |
16,105
-45,281
| -74% | -$2.09M |
|
2056
Jackson Financial
JXN
$8.8B
| $791K | ﹤0.01% |
11,965
-86,653
| -88% | -$4.71M |
|
2057
AtaiBeckley Inc
ATAI
$2.68B
| $790K | ﹤0.01% |
400,985
-14,758
| -4% | -$27.2K |
|
2058
Amalgamated Financial
AMAL
$1.49B
| $790K | ﹤0.01% |
+32,900
| New | +$808K |
|
2059
American Coastal Insurance
ACIC
$493M
| $788K | ﹤0.01% |
73,722
-59,750
| -45% | -$676K |
|
2060
OneSpaWorld
OSW
$2.66B
| $786K | ﹤0.01% |
59,412
-12,741
| -18% | -$172K |
|
2061
Beyond Meat
BYND
$277M
| $786K | ﹤0.01% |
94,916
-17,163
| -15% | -$132K |
|
2062
Spectrum Brands
SPB
$2.07B
| $783K | ﹤0.01% |
8,800
-13,900
| -61% | -$1.13M |
|
2063
The Greenbrier Companies
GBX
$1.46B
| $782K | ﹤0.01% |
15,000
-30,357
| -67% | -$1.46M |
|
2064
Aldeyra Therapeutics
ALDX
$93.5M
| $781K | ﹤0.01% |
238,964
+37,423
| +19% | +$123K |
|
2065
Procore
PCOR
$8.67B
| $781K | ﹤0.01% |
9,500
+1,000
| +12% | +$74.2K |
|
2066
Melco Resorts & Entertainment
MLCO
$2.14B
| $780K | ﹤0.01% |
108,174
-292,383
| -73% | -$2.35M |
|
2067
Marvell Technology
MRVL
$196B
| $780K | ﹤0.01% |
11,000
-30,100
| -73% | -$2.06M |
|
2068
Kornit Digital
KRNT
$791M
| $779K | ﹤0.01% |
43,000
-22,732
| -35% | -$398K |
|
2069
Capital City Bank Group
CCBG
$890M
| $778K | ﹤0.01% |
28,097
-999
| -3% | -$28.1K |
|
|
SHOE
2070
Shoe Station Group
SHOE
$428M
| $778K | ﹤0.01% |
21,236
-17,642
| -45% | -$522K |
|
2071
Stem
STEM
$52.7M
| $775K | ﹤0.01% |
17,685
+15,517
| +716% | +$863K |
|
|
DNB
2072
DELISTED
Dun & Bradstreet
DNB
| $774K | ﹤0.01% |
+77,125
| New | +$842K |
|
2073
Bumble
BMBL
$373M
| $773K | ﹤0.01% |
68,116
-795,720
| -92% | -$10.1M |
|
|
SUPV
2074
Grupo Supervielle
SUPV
$753M
| $772K | ﹤0.01% |
135,283
-240,209
| -64% | -$1.06M |
|
|
OLK
2075
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $771K | ﹤0.01% |
32,811
-36,904
| -53% | -$890K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.